MTNB

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Matinas BioPharma Holdings Inc

NYSE MKT | MTNB

1.65

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 21, 2025)

$9.66M

Market Cap

-

P/E Ratio

-3.87

EPS

$3.76

52 Week High

$0.47

52 Week Low

HEALTHCARE

Sector

MTNB Chart

Recent Chart
Price Action

MTNB Technicals

Tags:

MTNB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$972K
Total Revenue $0
Cost Of Revenue $972K
Costof Goods And Services Sold $972K
Operating Income -$20M
Selling General And Administrative $8.7M
Research And Development $11M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $972K
Income Before Tax -$24M
Income Tax Expense -$80K
Interest And Debt Expense -
Net Income From Continuing Operations -$24M
Comprehensive Income Net Of Tax -
Ebit -$24M
Ebitda -$23M
Net Income -$24M

Revenue & Profitability

Earnings Performance

MTNB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $13M
Total Current Assets $8M
Cash And Cash Equivalents At Carrying Value $7.3M
Cash And Short Term Investments $7.3M
Inventory -
Current Net Receivables -
Total Non Current Assets $4.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.3M
Intangible Assets Excluding Goodwill $2.3M
Goodwill $0
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $741K
Other Non Current Assets -
Total Liabilities $5.1M
Total Current Liabilities $2.7M
Current Accounts Payable $95K
Deferred Revenue -
Current Debt -
Short Term Debt $1.5M
Total Non Current Liabilities $2.4M
Capital Lease Obligations $2.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.9M
Other Current Liabilities $1M
Other Non Current Liabilities -
Total Shareholder Equity $7.6M
Treasury Stock -
Retained Earnings -$200M
Common Stock $1K
Common Stock Shares Outstanding $4.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$16M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $972K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $9.2M
Cashflow From Financing $9.2M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$24M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$972K
Total Revenue $0
Cost Of Revenue $972K
Costof Goods And Services Sold $972K
Operating Income -$20M
Selling General And Administrative $8.7M
Research And Development $11M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $972K
Income Before Tax -$24M
Income Tax Expense -$80K
Interest And Debt Expense -
Net Income From Continuing Operations -$24M
Comprehensive Income Net Of Tax -
Ebit -$24M
Ebitda -$23M
Net Income -$24M

MTNB Profile

Matinas BioPharma Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Matinas BioPharma Holdings, Inc. (MTNB) is a clinical-stage biopharmaceutical company headquartered in Bedminster, New Jersey, specializing in the development of innovative oral lipid-based delivery systems for therapeutics targeting infectious diseases and chronic conditions. The company aims to enhance treatment efficacy and patient adherence through its proprietary formulations, which are tailored to address significant unmet medical needs. With an expanding pipeline of candidate products and strategic collaborations, Matinas BioPharma presents a compelling investment opportunity in the biotechnology sector for institutional investors seeking innovative solutions in healthcare.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.